The Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Aryl Hydrocarbon Receptor Is Constitutively Active in Advanced Prostate Cancer Cells
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 4, Pages e95058
Publisher
Public Library of Science (PLoS)
Online
2014-04-23
DOI
10.1371/journal.pone.0095058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1
- (2014) Mateusz Kurzawski et al. Pharmacological Reports
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells
- (2012) Cindy Tran et al. BIOCHEMICAL PHARMACOLOGY
- Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor
- (2012) J. Brooks et al. CURRENT CANCER DRUG TARGETS
- Chemotherapy-Based Treatment for Castration-Resistant Prostate Cancer
- (2011) Bostjan Seruga et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the Aryl Hydrocarbon Receptor by TCDD Inhibits Mammary Tumor Metastasis in a Syngeneic Mouse Model of Breast Cancer
- (2011) Tao Wang et al. TOXICOLOGICAL SCIENCES
- Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands
- (2011) Eva Hrubá et al. TOXICOLOGY LETTERS
- Attenuation of cell cycle progression by 2,3,7,8-tetrachlorodibenzo-p-dioxin eliciting ovulatory blockade in gonadotropin-primed immature rats
- (2010) Nak-Kyun Jung et al. ENDOCRINE JOURNAL
- β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor
- (2010) Udi Gluschnaider et al. PLoS One
- The Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon Receptor
- (2009) Jennifer C. Schroeder et al. BIOCHEMISTRY
- Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells
- (2009) Noriko Sanada et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity
- (2009) Alexandra Kollara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
- (2009) M. A. Barhoover et al. MOLECULAR PHARMACOLOGY
- The androgen receptor in hormone-refractory prostate cancer
- (2008) Hai-Lei Mao et al. ASIAN JOURNAL OF ANDROLOGY
- AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions
- (2008) Fumiaki Ohtake et al. BIOCHEMICAL PHARMACOLOGY
- Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2
- (2008) Alexandra Kollara et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Constitutive regulation ofCYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue
- (2007) Xinhai Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started